However, the same OR has also been shown to stimulate cancer cell invasiveness (Sanz et al., 2014), and overexpression of PSGR in mouse tumors suggests a role for this receptor in tumor development (Rodriguez et al., 2014). This evidence concerns the gene OR51E2 and cancer.